PET-CT Scanner Device Market

Market Overview:

The global PET-CT scanner device market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2028, exhibiting a growth rate (CAGR) of 3.93% during 2023-2028.

Positron emission tomography (PET)-computed tomography (CT) scanner devices refer to medical equipment that examines and measures the metabolic activity of the tissues and cells of the body. They are commonly available in stationary, portable and mobile scanner variants. They consist of a machine with a round, donut-shaped hole in the middle and require a camera and a computer to evaluate tissue and organ functions. PET-CT scanner devices are widely used in cardiology, neurology and oncology departments to detect early signs of cancer, heart disease and brain disorders. They are non-invasive, accurate, painless and assist in increasing patient comfort and convenience. As a result, these devices are widely used in research institutes, hospitals and diagnostic centers.

PET-CT Scanner Device Market Trends:

The rising prevalence of chronic diseases across the world is creating a positive outlook for the market. PET-CT scanner device is widely used to measure body functions, such as glucose metabolism, oxygen usage and blood flow. Additionally, the widespread product utilization to diagnose gastrointestinal, endocrine, cancer, heart diseases and neurological disorders due to the increasing demand for better and reliable medical solutions and diagnoses is positively impacting the market growth. Moreover, various product innovations, such as the launch of portable scanner devices that offer increased mobility, shorter installation time, and decreased downtime, are providing an impetus to the market growth. Continuous product improvements are further assisting medical practitioners in recognizing unusual or irregular sites, classifying inflammatory injuries and identifying serendipitous anomalies. This, in turn, is favoring the market growth. Other factors, including rising in patient awareness regarding non-invasive procedures, increasing research and development (R&D) activities and significant improvements in healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global PET-CT scanner device market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, slice count, isotope and detector type, service provider and application.

Breakup by Type:

• Stationary Scanners
• Portable Scanners/Mobile Scanners
   

Breakup by Slice Count:

• Low Slice Scanner (<64 Slices)
• Medium Slice Scanner (64 Slices)
• High Slice Scanner (>64 Slices)
   

Breakup by Isotope and Detector Type:

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• Gallium
• Thallium
• Others
   

Breakup by Service Provider:

• Hospitals
• Diagnostic Centers
• Research Institutes
   

Breakup by Application:

• Oncology
• Neurology
• Cardiology
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bruker Corporation, Canon Medical Systems Usa Inc., General Electric Company, Hitachi Ltd., Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Positron Corporation, Shimadzu Corporation, Siemens Healthcare GmbH (Siemens AG), Sofie Biosciences Inc., United Imaging Healthcare Co. Ltd. and Yangzhou Kindsway Biotech Co. Ltd.

Report Coverage: